Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease.

Madhuri Venigalla, Erika Gyengesi, Gerald Münch

Review Neural regeneration research 2015 161 Zitierungen

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'pmid\u003D26487830'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

Studientyp: Review
Population: Alzheimer's disease patients

Intervention: Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease. None
Vergleichsgruppe: None
Primärer Endpunkt: None
Wirkungsrichtung: Positive
Verzerrungsrisiko: Unclear

Abstract

Alzheimer's disease is a progressive neurodegenerative disorder, characterized by deposition of amyloid beta, neurofibrillary tangles, astrogliosis and microgliosis, leading to neuronal dysfunction and loss in the brain. Current treatments for Alzheimer's disease primarily focus on enhancement of cholinergic transmission. However, these treatments are only symptomatic, and no disease-modifying drug is available for Alzheimer's disease patients. This review will provide an overview of the proven antioxidant, anti-inflammatory, anti-amyloidogenic, neuroprotective, and cognition-enhancing effects of curcumin and apigenin and discuss the potential of these compounds for Alzheimer's disease prevention and treatment. We suggest that these compounds might delay the onset of Alzheimer's disease or slow down its progression, and they should enter clinical trials as soon as possible.

Zusammenfassung

It is suggested that curcumin and apigenin might delay the onset of Alzheimer′s disease or slow down its progression, and they should enter clinical trials as soon as possible.

Used In Evidence Reviews

B Curcumin für Oxidative Stress & Neuroinflammation

Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease.

Embed This Widget

Study Design

Abstract

Zusammenfassung

Used In Evidence Reviews

Similar Papers

Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway.

Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells.

Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.

Neuroinflammation, neurodegeneration, and depression.

Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function.

Antioxidant strategies for Alzheimer's disease.